Aricept, Exelon, Reminyl, and Cognex seem to help only those with mild or
moderate symptoms of Alzheimer's disease. Namenda is prescribed for patients who
have moderate-to-severe Alzheimer’s.
It is important to know that new research findings are giving reason for hope,
and several drugs are being studied in clinical trials to determine if they can
slow the progression of the disease, or improve memory or other symptoms for a period of time.
A vaccine has also been studied. However, because of unwanted side effects, the
initial clinical trial was stopped. Studies are underway to modify the vaccine
for improved safety. A number of other therapeutic approaches are being actively investigated.
References
Alzheimer’s Association. Treatment: Medications for Memory Loss.
www.alz.org. Accessed 12/27/2010.
National Institute on Aging. Alzheimer’s Disease Education and Referral Center. Alzheimer’s Information: Treatment.
www.nia.nih.gov. Accessed 12/17/2010